本页面由Tiger Trade Technology Pte. Ltd.提供服务

Amylyx Pharmaceuticals

18.41
+0.82004.66%
盘后18.24-0.1700-0.92%19:34 EDT
成交量:163.45万
成交额:2,938.12万
市值:20.47亿
市盈率:-12.36
高:18.42
开:17.61
低:17.22
收:17.59
52周最高:19.15
52周最低:7.48
股本:1.11亿
流通股本:9,409.97万
量比:1.05
换手率:1.74%
股息:- -
股息率:- -
每股收益(TTM):-1.4895
每股收益(LYR):-1.5305
净资产收益率:-63.26%
总资产收益率:-38.79%
市净率:7.49
市盈率(LYR):-12.03

数据加载中...

2026/07/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/04

重要事件披露

Form 8-K - Current report
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/07

重要事件披露

Form 8-K - Current report
2026/03/24

重要事件披露

Form 8-K - Current report
2026/03/03

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/03

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/03

重要事件披露

Form 8-K - Current report
2026/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities